PURPOSE: This study is aimed at demonstrating the in vivo potential of Gd(III)-loaded glucan particles (Gd-GPs) as magnetic resonance imaging (MRI)-positive agents for labeling and tracking phagocytic cells. PROCEDURE: GPs were obtained from Saccharomyces cerevisae and loaded with the water-insoluble complex Gd-DOTAMA(C18)2. The uptake kinetics of Gd-GPs by murine macrophages was studied in vitro and the internalization mechanism was assessed by competition assays. The in vivo performance of Gd-GPs was tested at 7.05 T on a mouse model of acute liver inflammation. RESULTS: The minimum number of Gd-GPs-labeled J774.A1 macrophages detected in vitro by MRI was ca. 300 cells/μl of agar, which is the lowest number ever reported for cells labeled with a positive T1 agent. Intravenous injection of macrophages labeled with Gd-GPs in a mouse model of liver inflammation enabled the MRI visualization of the cellular infiltration in the diseased area. CONCLUSIONS: Gd-GPs represent a promising platform for tracking macrophages by MRI as a T1 alternative to the golden standard T2-based iron oxide particles.
PURPOSE: This study is aimed at demonstrating the in vivo potential of Gd(III)-loaded glucan particles (Gd-GPs) as magnetic resonance imaging (MRI)-positive agents for labeling and tracking phagocytic cells. PROCEDURE: GPs were obtained from Saccharomyces cerevisae and loaded with the water-insoluble complex Gd-DOTAMA(C18)2. The uptake kinetics of Gd-GPs by murine macrophages was studied in vitro and the internalization mechanism was assessed by competition assays. The in vivo performance of Gd-GPs was tested at 7.05 T on a mouse model of acute liver inflammation. RESULTS: The minimum number of Gd-GPs-labeled J774.A1 macrophages detected in vitro by MRI was ca. 300 cells/μl of agar, which is the lowest number ever reported for cells labeled with a positive T1 agent. Intravenous injection of macrophages labeled with Gd-GPs in a mouse model of liver inflammation enabled the MRI visualization of the cellular infiltration in the diseased area. CONCLUSIONS:Gd-GPs represent a promising platform for tracking macrophages by MRI as a T1 alternative to the golden standard T2-based iron oxide particles.
Authors: Erik M Shapiro; Oscar Gonzalez-Perez; Jose Manuel García-Verdugo; Arturo Alvarez-Buylla; Alan P Koretsky Journal: Neuroimage Date: 2006-06-30 Impact factor: 6.556
Authors: Sara Figueiredo; João Nuno Moreira; Carlos F G C Geraldes; Silvia Rizzitelli; Silvio Aime; Enzo Terreno Journal: Chem Commun (Camb) Date: 2011-09-01 Impact factor: 6.222
Authors: Jamal Guenoun; Gerben A Koning; Gabriela Doeswijk; Lizanne Bosman; Piotr A Wielopolski; Gabriel P Krestin; Monique R Bernsen Journal: Cell Transplant Date: 2011-09-16 Impact factor: 4.064
Authors: Inga E Haedicke; Tan Li; Yong Le K Zhu; Francisco Martinez; Amanda M Hamilton; Donna H Murrell; Joris T Nofiele; Hai-Ling M Cheng; Timothy J Scholl; Paula J Foster; Xiao-An Zhang Journal: Chem Sci Date: 2016-03-16 Impact factor: 9.825
Authors: Georgi Atanasov; Hans-Michael Hau; Corinna Dietel; Christian Benzing; Felix Krenzien; Andreas Brandl; Georg Wiltberger; Ivan Matia; Isabel Prager; Katrin Schierle; Simon C Robson; Anja Reutzel-Selke; Johann Pratschke; Moritz Schmelzle; Sven Jonas Journal: BMC Cancer Date: 2015-10-24 Impact factor: 4.430
Authors: Rajiv Ramasawmy; S Peter Johnson; Thomas A Roberts; Daniel J Stuckey; Anna L David; R Barbara Pedley; Mark F Lythgoe; Bernard Siow; Simon Walker-Samuel Journal: PLoS One Date: 2016-05-25 Impact factor: 3.240